HeartMate 3 Heart Pump Approved for Patients Not Eligible for Transplant

Abbott‘s HeartMate 3 left ventricular assist device (LVAD) won FDA approval to be used as a destination therapy for advanced heart failure patients who are not eligible for a transplant. Previously, the device has been indicated for patients eligible for and waiting for a transplant.

Since transplant hearts are rarely available and not all (Read more...)

Full Story →